Revance Therapeutics, Inc. RVNC
Trading inactive
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Vamil Divan | Mizuho Securities | 5.955 $ | 6.66 $ | 0.71 % | 17/09/2024 |
| David Amsellem | Piper Sandler | 3.735 $ | 11 $ | 7.27 % | 10/05/2024 |
| Douglas Tsao | H.C. Wainwright | 4.29 $ | 11 $ | 6.71 % | 10/05/2024 |
| Vamil Divan | Mizuho Securities | 3.7301 $ | 8 $ | 4.27 % | 10/05/2024 |
| Serge Belanger | Needham | 13.48 $ | 35 $ | 21.52 % | 20/09/2023 |
| Jacob Hughes | Wells Fargo | 21.26 $ | 24 $ | 2.74 % | 25/08/2022 |